retatrutide weight loss trial data VisualAbstract: reduces body by 17.5% in patients with obesity New Phase 3 retatrutide data

Cardiovascular outcome trials for liraglutide, semaglutide, and dulaglutide demonstrated modest blood pressure reductions alongside reduced major adverse cardiovascular events

EMA Statement on Ongoing Review of GLP-1 Receptor Agonists (EMA, 2023)

27,28 Table 1 details additional studies that show a higher prevalence of caries in those with ASD

Should you stop taking the injections

For more deep dives into the science of peptides and cellular health, we regularly post updates and educational content on our YouTube channel and invite you to join the conversation on our Facebook page

Cognition Its uncertain how L-carnitine affects cognition since clinical trials are limited